IB’S MR Perfusion Software Will Evaluate Mechanisms of AntiAngiogenic Drugs
Friday, 28 September 2018
/
Published in IB Corporate News & Announcements, IQ-AI News & Announcements
iq-ai@imagingbiometrics.com
IFC5
St Helier, Jersey, Channel Islands
JE1 1ST